The best objective response of target lesions and the incidence of treatment-related hypertension are associated with the survival of patients with metastatic renal cell carcinoma treated with sunitinib: a Japanese retrospective study.

MLA

Miyake, Makito, et al. “The Best Objective Response of Target Lesions and the Incidence of Treatment-Related Hypertension Are Associated with the Survival of Patients with Metastatic Renal Cell Carcinoma Treated with Sunitinib: A Japanese Retrospective Study.” BMC Research Notes, vol. 9, Feb. 2016, p. 79. EBSCOhost, https://doi.org/10.1186/s13104-016-1895-8.

APA

Miyake, M., Kuwada, M., Hori, S., Morizawa, Y., Tatsumi, Y., Anai, S., Hosokawa, Y., Hayashi, Y., Tomioka, A., Otani, T., Otsuka, K., Nakagawa, Y., Nakai, Y., Samma, S., Tanaka, N., & Fujimoto, K. (2016). The best objective response of target lesions and the incidence of treatment-related hypertension are associated with the survival of patients with metastatic renal cell carcinoma treated with sunitinib: a Japanese retrospective study. BMC Research Notes, 9, 79. https://doi.org/10.1186/s13104-016-1895-8

Chicago

Miyake, Makito, Masaomi Kuwada, Shunta Hori, Yosuke Morizawa, Yoshihiro Tatsumi, Satoshi Anai, Yukinari Hosokawa, et al. 2016. “The Best Objective Response of Target Lesions and the Incidence of Treatment-Related Hypertension Are Associated with the Survival of Patients with Metastatic Renal Cell Carcinoma Treated with Sunitinib: A Japanese Retrospective Study.” BMC Research Notes 9 (February): 79. doi:10.1186/s13104-016-1895-8.